PRESS RELEASE: Sign Up for a Complimentary Trial to Inside AI Policy

PRESS RELEASE
Contact: Steve Reilly
Phone: (703)-562-8992
Email: sreilly@iwpnews.com
Website: www.InsideAIPolicy.com


WASHINGTON, DC USA -- HEALTHCARE UPDATE NEWS SERVICE™ -- NOVEMBER 30, 2023: Artificial intelligence (AI) is a transformational technology, promising big breakthroughs and efficiencies for manufacturing, supply chains, healthcare delivery, environmental protections, global markets, data management and security, communications, and national and energy security — to name just a few areas where it is expected to reshape the economy.

In the dynamic landscape of healthcare, staying informed is not just a choice—it's a necessity. The future of medicine is here, and artificial intelligence is at the forefront of this revolution. Inside AI Policy offers exclusive news and analysis to keep you informed about the latest policies and regulatory changes in the AI landscape.

From legislation to regulation — at both the federal and state levels — to emerging global requirements, Inside AI Policy will report on the leading proposals so you can stay ahead of the curve on new standards and rules before they are adopted.

Sign up for a free trial subscription to Inside AI Policy, the online news service on AI policy from the regulatory reporting experts at Inside Washington Publishers.

Here is a sample of the latest Inside AI Policy stories covering artificial intelligence, the hottest issue in healthcare. You can read these stories, and many more, with your free trial:

  • Congressional testimony highlights potential regulatory vacuum for AI consumer health application
    Witnesses set to testify before the House Energy and Commerce health subcommittee differ over the extent to which satisfactory oversight of artificial intelligence is occurring for tools that promise to reduce healthcare workers' burnout by minimizing certain interactions between patients and clinicians, along with other potential benefits.
  • Senate resumes work on AI benefits and risks amid push for year-end legislative action
    The Senate returns this week to resume its closed-door meetings on promoting the benefits and managing the risks of artificial intelligence, amid a push by the chamber's leaders on end-of-year legislative actions that likely will include some AI provisions.
  • FTC approves 'streamlined' authority to obtain information in AI-related investigations
    The Federal Trade Commission has approved on a 3-0 vote an "omnibus resolution" allowing the use of a compulsory process to obtain documents and other information in investigations related to artificial intelligence products and services.
  • NIST kicks off AI Safety Institute by stressing long view for establishing ecosystem of trustworthiness
    Senior officials at the National Institute of Standards and Technology marked the launch of its AI Safety Institute for testing and evaluating artificial intelligence systems by stressing that collaboration with the private sector and academia on research will set the basis for an enduring ecosystem of trustworthy AI systems.

You can try Inside AI Policy for the next month with absolutely no obligation, your trial will simply expire at the end of 30 days. Plus, if you choose to subscribe, we'll offer you 25% off for the first year of access.

For more information about the 25% off, first-year savings, contact Steve Reilly at 703-562-8992, or e-mail him at sreilly@iwpnews.com.

FOR E-MAIL ADDRESS CHANGE, ADD OR DELETE REQUESTS:

For changes or additions, please email your request to: listmgrbm@HealthCareUpdateNewsService.com.

For removal of your e-mail address, please click the "SafeUnsubscribe" link located in the footer of this message below to automatically remove your address from the list.